Edition:
United Kingdom

PRA Health Sciences Inc (PRAH.OQ)

PRAH.OQ on NASDAQ Stock Exchange Global Select Market

84.61USD
12 Dec 2017
Change (% chg)

$0.86 (+1.03%)
Prev Close
$83.75
Open
$83.85
Day's High
$84.86
Day's Low
$83.41
Volume
141,661
Avg. Vol
222,299
52-wk High
$84.86
52-wk Low
$53.48

Latest Key Developments (Source: Significant Developments)

PRA Health Sciences reports Q3 adjusted earnings per share $0.88
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - PRA Health Sciences Inc :PRA Health Sciences, Inc reports third quarter 2017 results and updates full year 2017 guidance.Q3 adjusted earnings per share $0.88.Q3 GAAP earnings per share $0.73.Q3 earnings per share view $0.85 -- Thomson Reuters I/B/E/S.PRA Health Sciences Inc says ‍updating full year 2017 service revenue guidance to between $1.914 billion and $1.926 billion​.PRA Health Sciences Inc sees ‍full year 2017 GAAP net income per diluted share to between $2.31 and $2.38​.PRA Health Sciences Inc sees ‍full year 2017 adjusted net income per diluted share to between $3.28 and $3.35​.FY2017 earnings per share view $3.20, revenue view $1.91 billion -- Thomson Reuters I/B/E/S.PRA Health Sciences Inc qtrly ‍total revenue $582 million versus $453.3 million.  Full Article

Takeda Pharmaceutical says PRA Health Sciences and Takeda Partnership Expands to Japan
Wednesday, 15 Feb 2017 

Takeda Pharmaceutical Co Ltd <4502.T>: Says PRA Health Sciences Inc and Takeda Pharmaceutical Company Limited have agreed to a new partnership to expand their global relationship initially disclosed in September 2016 to include Japan . Says Takeda and PRA will establish a joint venture, each holding 50 percent of the share respectively, to provide clinical trial delivery and pharmacovigilance services as a strategic partner of Takeda in Japan. .Says Takeda also will transfer all of the shares of Takeda Pharmaceutical Data Services (TDS), a wholly-owned subsidiary of Takeda, to PRA.  Full Article

PRA Health Sciences Q2 GAAP net income per diluted share $0.60
Thursday, 28 Jul 2016 

Pra Health Sciences Inc : Says $394.2 million of service revenue in Q2, 17.3 pct constant currency growth compared to Q2 of 2015 . Q2 GAAP net income per diluted share increased 200.0 pct to $0.60 per diluted share . Qtrly adjusted net income per share was $0.63 .Q2 earnings per share view $0.58, revenue view $381.2 million -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-PRA Health Sciences reports Q3 adjusted earnings per share $0.88

* PRA Health Sciences, Inc reports third quarter 2017 results and updates full year 2017 guidance